United States Erlotinib Hydrochloride Market Report 2017

December 2017 | 100 pages | ID: UD10A3EB4CCEN
QYResearch

Abstracts

In this report, the United States Erlotinib Hydrochloride market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Erlotinib Hydrochloride in these regions, from 2012 to 2022 (forecast).

United States Erlotinib Hydrochloride market competition by top manufacturers/players, with Erlotinib Hydrochloride sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• HEC Pharm
• Arasto Pharmaceutical Chemicals Inc.
• Tava
• Polpharma Pharmaceutical Works
• Suanfarma
• Natco Pharma
• Tecoland
• Shanghai Biosundrug Co., Ltd.
• Shilpa Medicare Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• 25 mg Tablet
• 100 mg Tablet
• 150 mg Tablet

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Non-Small Cell Lung Cancer (NSCLC)
• Pancreatic Cancer
• Other Types of Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Erlotinib Hydrochloride Market Report 2017

1 ERLOTINIB HYDROCHLORIDE OVERVIEW

1.1 Product Overview and Scope of Erlotinib Hydrochloride
1.2 Classification of Erlotinib Hydrochloride by Product Category
  1.2.1 United States Erlotinib Hydrochloride Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Erlotinib Hydrochloride Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 25 mg Tablet
  1.2.4 100 mg Tablet
  1.2.5 150 mg Tablet
1.3 United States Erlotinib Hydrochloride Market by Application/End Users
  1.3.1 United States Erlotinib Hydrochloride Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Non-Small Cell Lung Cancer (NSCLC)
  1.3.3 Pancreatic Cancer
  1.3.4 Other Types of Cancer
1.4 United States Erlotinib Hydrochloride Market by Region
  1.4.1 United States Erlotinib Hydrochloride Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Erlotinib Hydrochloride Status and Prospect (2012-2022)
  1.4.3 Southwest Erlotinib Hydrochloride Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Erlotinib Hydrochloride Status and Prospect (2012-2022)
  1.4.5 New England Erlotinib Hydrochloride Status and Prospect (2012-2022)
  1.4.6 The South Erlotinib Hydrochloride Status and Prospect (2012-2022)
  1.4.7 The Midwest Erlotinib Hydrochloride Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Erlotinib Hydrochloride (2012-2022)
  1.5.1 United States Erlotinib Hydrochloride Sales and Growth Rate (2012-2022)
  1.5.2 United States Erlotinib Hydrochloride Revenue and Growth Rate (2012-2022)

2 UNITED STATES ERLOTINIB HYDROCHLORIDE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Erlotinib Hydrochloride Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Erlotinib Hydrochloride Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Erlotinib Hydrochloride Average Price by Players/Suppliers (2012-2017)
2.4 United States Erlotinib Hydrochloride Market Competitive Situation and Trends
  2.4.1 United States Erlotinib Hydrochloride Market Concentration Rate
  2.4.2 United States Erlotinib Hydrochloride Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Erlotinib Hydrochloride Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ERLOTINIB HYDROCHLORIDE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Erlotinib Hydrochloride Sales and Market Share by Region (2012-2017)
3.2 United States Erlotinib Hydrochloride Revenue and Market Share by Region (2012-2017)
3.3 United States Erlotinib Hydrochloride Price by Region (2012-2017)

4 UNITED STATES ERLOTINIB HYDROCHLORIDE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Erlotinib Hydrochloride Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Erlotinib Hydrochloride Revenue and Market Share by Type (2012-2017)
4.3 United States Erlotinib Hydrochloride Price by Type (2012-2017)
4.4 United States Erlotinib Hydrochloride Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ERLOTINIB HYDROCHLORIDE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Erlotinib Hydrochloride Sales and Market Share by Application (2012-2017)
5.2 United States Erlotinib Hydrochloride Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ERLOTINIB HYDROCHLORIDE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 HEC Pharm
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Erlotinib Hydrochloride Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 HEC Pharm Erlotinib Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Arasto Pharmaceutical Chemicals Inc.
  6.2.2 Erlotinib Hydrochloride Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Tava
  6.3.2 Erlotinib Hydrochloride Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Tava Erlotinib Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Polpharma Pharmaceutical Works
  6.4.2 Erlotinib Hydrochloride Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Polpharma Pharmaceutical Works Erlotinib Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Suanfarma
  6.5.2 Erlotinib Hydrochloride Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Suanfarma Erlotinib Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Natco Pharma
  6.6.2 Erlotinib Hydrochloride Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Natco Pharma Erlotinib Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Tecoland
  6.7.2 Erlotinib Hydrochloride Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Tecoland Erlotinib Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Shanghai Biosundrug Co., Ltd.
  6.8.2 Erlotinib Hydrochloride Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Shilpa Medicare Ltd.
  6.9.2 Erlotinib Hydrochloride Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Shilpa Medicare Ltd. Erlotinib Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 ERLOTINIB HYDROCHLORIDE MANUFACTURING COST ANALYSIS

7.1 Erlotinib Hydrochloride Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Erlotinib Hydrochloride

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Erlotinib Hydrochloride Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Erlotinib Hydrochloride Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ERLOTINIB HYDROCHLORIDE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Erlotinib Hydrochloride Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Erlotinib Hydrochloride Sales Volume Forecast by Type (2017-2022)
11.3 United States Erlotinib Hydrochloride Sales Volume Forecast by Application (2017-2022)
11.4 United States Erlotinib Hydrochloride Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Erlotinib Hydrochloride
Figure United States Erlotinib Hydrochloride Market Size (K Units) by Type (2012-2022)
Figure United States Erlotinib Hydrochloride Sales Volume Market Share by Type (Product Category) in 2016
Figure 25 mg Tablet Product Picture
Figure 100 mg Tablet Product Picture
Figure 150 mg Tablet Product Picture
Figure United States Erlotinib Hydrochloride Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Erlotinib Hydrochloride by Application in 2016
Figure Non-Small Cell Lung Cancer (NSCLC) Examples
Table Key Downstream Customer in Non-Small Cell Lung Cancer (NSCLC)
Figure Pancreatic Cancer Examples
Table Key Downstream Customer in Pancreatic Cancer
Figure Other Types of Cancer Examples
Table Key Downstream Customer in Other Types of Cancer
Figure United States Erlotinib Hydrochloride Market Size (Million USD) by Region (2012-2022)
Figure The West Erlotinib Hydrochloride Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Erlotinib Hydrochloride Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Erlotinib Hydrochloride Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Erlotinib Hydrochloride Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Erlotinib Hydrochloride Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Erlotinib Hydrochloride Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Erlotinib Hydrochloride Sales (K Units) and Growth Rate (2012-2022)
Figure United States Erlotinib Hydrochloride Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Erlotinib Hydrochloride Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Erlotinib Hydrochloride Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Erlotinib Hydrochloride Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Erlotinib Hydrochloride Sales Share by Players/Suppliers
Figure 2017 United States Erlotinib Hydrochloride Sales Share by Players/Suppliers
Figure United States Erlotinib Hydrochloride Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Erlotinib Hydrochloride Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Erlotinib Hydrochloride Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Erlotinib Hydrochloride Revenue Share by Players/Suppliers
Figure 2017 United States Erlotinib Hydrochloride Revenue Share by Players/Suppliers
Table United States Market Erlotinib Hydrochloride Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Erlotinib Hydrochloride Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Erlotinib Hydrochloride Market Share of Top 3 Players/Suppliers
Figure United States Erlotinib Hydrochloride Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Erlotinib Hydrochloride Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Erlotinib Hydrochloride Product Category
Table United States Erlotinib Hydrochloride Sales (K Units) by Region (2012-2017)
Table United States Erlotinib Hydrochloride Sales Share by Region (2012-2017)
Figure United States Erlotinib Hydrochloride Sales Share by Region (2012-2017)
Figure United States Erlotinib Hydrochloride Sales Market Share by Region in 2016
Table United States Erlotinib Hydrochloride Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Erlotinib Hydrochloride Revenue Share by Region (2012-2017)
Figure United States Erlotinib Hydrochloride Revenue Market Share by Region (2012-2017)
Figure United States Erlotinib Hydrochloride Revenue Market Share by Region in 2016
Table United States Erlotinib Hydrochloride Price (USD/Unit) by Region (2012-2017)
Table United States Erlotinib Hydrochloride Sales (K Units) by Type (2012-2017)
Table United States Erlotinib Hydrochloride Sales Share by Type (2012-2017)
Figure United States Erlotinib Hydrochloride Sales Share by Type (2012-2017)
Figure United States Erlotinib Hydrochloride Sales Market Share by Type in 2016
Table United States Erlotinib Hydrochloride Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Erlotinib Hydrochloride Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Erlotinib Hydrochloride by Type (2012-2017)
Figure Revenue Market Share of Erlotinib Hydrochloride by Type in 2016
Table United States Erlotinib Hydrochloride Price (USD/Unit) by Types (2012-2017)
Figure United States Erlotinib Hydrochloride Sales Growth Rate by Type (2012-2017)
Table United States Erlotinib Hydrochloride Sales (K Units) by Application (2012-2017)
Table United States Erlotinib Hydrochloride Sales Market Share by Application (2012-2017)
Figure United States Erlotinib Hydrochloride Sales Market Share by Application (2012-2017)
Figure United States Erlotinib Hydrochloride Sales Market Share by Application in 2016
Table United States Erlotinib Hydrochloride Sales Growth Rate by Application (2012-2017)
Figure United States Erlotinib Hydrochloride Sales Growth Rate by Application (2012-2017)
Table HEC Pharm Basic Information List
Table HEC Pharm Erlotinib Hydrochloride Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure HEC Pharm Erlotinib Hydrochloride Sales Growth Rate (2012-2017)
Figure HEC Pharm Erlotinib Hydrochloride Sales Market Share in United States (2012-2017)
Figure HEC Pharm Erlotinib Hydrochloride Revenue Market Share in United States (2012-2017)
Table Arasto Pharmaceutical Chemicals Inc. Basic Information List
Table Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Sales Growth Rate (2012-2017)
Figure Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Sales Market Share in United States (2012-2017)
Figure Arasto Pharmaceutical Chemicals Inc. Erlotinib Hydrochloride Revenue Market Share in United States (2012-2017)
Table Tava Basic Information List
Table Tava Erlotinib Hydrochloride Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Tava Erlotinib Hydrochloride Sales Growth Rate (2012-2017)
Figure Tava Erlotinib Hydrochloride Sales Market Share in United States (2012-2017)
Figure Tava Erlotinib Hydrochloride Revenue Market Share in United States (2012-2017)
Table Polpharma Pharmaceutical Works Basic Information List
Table Polpharma Pharmaceutical Works Erlotinib Hydrochloride Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Polpharma Pharmaceutical Works Erlotinib Hydrochloride Sales Growth Rate (2012-2017)
Figure Polpharma Pharmaceutical Works Erlotinib Hydrochloride Sales Market Share in United States (2012-2017)
Figure Polpharma Pharmaceutical Works Erlotinib Hydrochloride Revenue Market Share in United States (2012-2017)
Table Suanfarma Basic Information List
Table Suanfarma Erlotinib Hydrochloride Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Suanfarma Erlotinib Hydrochloride Sales Growth Rate (2012-2017)
Figure Suanfarma Erlotinib Hydrochloride Sales Market Share in United States (2012-2017)
Figure Suanfarma Erlotinib Hydrochloride Revenue Market Share in United States (2012-2017)
Table Natco Pharma Basic Information List
Table Natco Pharma Erlotinib Hydrochloride Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Natco Pharma Erlotinib Hydrochloride Sales Growth Rate (2012-2017)
Figure Natco Pharma Erlotinib Hydrochloride Sales Market Share in United States (2012-2017)
Figure Natco Pharma Erlotinib Hydrochloride Revenue Market Share in United States (2012-2017)
Table Tecoland Basic Information List
Table Tecoland Erlotinib Hydrochloride Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Tecoland Erlotinib Hydrochloride Sales Growth Rate (2012-2017)
Figure Tecoland Erlotinib Hydrochloride Sales Market Share in United States (2012-2017)
Figure Tecoland Erlotinib Hydrochloride Revenue Market Share in United States (2012-2017)
Table Shanghai Biosundrug Co., Ltd. Basic Information List
Table Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Sales Growth Rate (2012-2017)
Figure Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Sales Market Share in United States (2012-2017)
Figure Shanghai Biosundrug Co., Ltd. Erlotinib Hydrochloride Revenue Market Share in United States (2012-2017)
Table Shilpa Medicare Ltd. Basic Information List
Table Shilpa Medicare Ltd. Erlotinib Hydrochloride Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shilpa Medicare Ltd. Erlotinib Hydrochloride Sales Growth Rate (2012-2017)
Figure Shilpa Medicare Ltd. Erlotinib Hydrochloride Sales Market Share in United States (2012-2017)
Figure Shilpa Medicare Ltd. Erlotinib Hydrochloride Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Erlotinib Hydrochloride
Figure Manufacturing Process Analysis of Erlotinib Hydrochloride
Figure Erlotinib Hydrochloride Industrial Chain Analysis
Table Raw Materials Sources of Erlotinib Hydrochloride Major Players/Suppliers in 2016
Table Major Buyers of Erlotinib Hydrochloride
Table Distributors/Traders List
Figure United States Erlotinib Hydrochloride Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Erlotinib Hydrochloride Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Erlotinib Hydrochloride Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Erlotinib Hydrochloride Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Erlotinib Hydrochloride Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Erlotinib Hydrochloride Sales Volume (K Units) Forecast by Type in 2022
Table United States Erlotinib Hydrochloride Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Erlotinib Hydrochloride Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Erlotinib Hydrochloride Sales Volume (K Units) Forecast by Application in 2022
Table United States Erlotinib Hydrochloride Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Erlotinib Hydrochloride Sales Volume Share Forecast by Region (2017-2022)
Figure United States Erlotinib Hydrochloride Sales Volume Share Forecast by Region (2017-2022)
Figure United States Erlotinib Hydrochloride Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources